about
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation.HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cellsLow and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic functionS100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Anne Ernst
@en
Anne Ernst
@nl
type
label
Anne Ernst
@en
Anne Ernst
@nl
prefLabel
Anne Ernst
@en
Anne Ernst
@nl
P31
P496
0000-0002-1420-1693